-
Gizmodo |
A handheld microscope designed at the University of Washington produces rapid imaging of tissues at a resolution that its creators say could be enough to identify tumor cells.
Jan 26, 2016
-
Wall Street Journal |
John Carreyrou reports that U.S. health inspectors have found serious deficiencies at Theranos' laboratory in Northern California, and uncovers new details about outsourcing of tests and the agreement tying the company to Walgreens.
Jan 25, 2016
-
Diagnostics World | Oracle Health Sciences today announced Oracle Healthcare Precision Medicine, a software solution to connect genetic testing, report generation, and clinical care decision-making.
Jan 25, 2016
-
STAT |
A huge trial of personalized cancer medicine has run into an unexpected roadblock: many tumor samples aren't robust enough to put through genetic analysis.
Jan 22, 2016
-
Diagnostics World | Exosome Diagnostics of Cambridge, Mass., opened sales this morning of a blood test for patients with non-small-cell lung cancer, sequencing RNA from the exosomes released by cancer cells to find mutations that may indicate new courses of treatment.
Jan 21, 2016
-
Diagnostics World Brief | Ambry Genetics today announced a new suite of genetic tests for neurodevelopmental disorders. The panels are available now and cover intellectual disability, autism, neurodevelopment, Rett and Angelman syndromes.
Jan 20, 2016
-
The Atlantic |
They can measure pressure, temperature, and much more before being safely absorbed into the body.
Jan 19, 2016
-
The Conversation |
Computer systems are poised to overtake the accuracy and efficiency of human interpreters in both in vitro and imaging tests, fundamentally changing the role of physicians.
Jan 18, 2016
-
GEN |
Cepheid will use newly adapted Xpert tests for common hospital associated infections as codiagnostics to support MedImmune's clinical trials of a new anti-infective biologic drug.
Jan 15, 2016
-
Diagnostics World | Illumina, the dominant manufacturer of DNA sequencing technology, has
formed a spinoff company called GRAIL to experiment with a pan-cancer
blood test, an undertaking for which hundreds of thousands of patients
may be enrolled in clinical studies.
Jan 11, 2016
-
San Francisco Business Times |
OrbiMed Advisors led the Series D financing for this San Francisco company, which for 18 months has had a product on the market to detect cancer through a simple blood draw.
Jan 7, 2016
-
Diagnostics World | IQuity Labs, a diagnostics company spun out from research at Vanderbilt University Medical Center, today announced that it has raised $2 million in seed funding to support the rollout of its first test in the second quarter of this year.
Jan 7, 2016
-
FierceMedicalDevices |
The FDA has cleared iHear Medical's hearing test for home use, as the agency looks to crack down on unreliable online assessments.
Jan 6, 2016
-
Diagnostics World Brief | Scientists at the Fraunhofer Institute for Cell Therapy and Immunology have announced the creation of a specific antibody test for dengue fever, capable of ruling out related infections like West Nile virus.
Jan 5, 2016
-
Triad Business Journal |
The $225,000 penalty follows an investigation by the New York attorney general's office into improperly ordered direct-to-consumer medical tests.
Jan 4, 2016
-
Wall Street Journal | The blood-testing company founded by Elizabeth Holmes in 2003 has continually reinvented its approach and priorities as it fought to bring its low-cost, low-volume tests to market, but it has been dogged throughout by troubling accusations about its performance.
Dec 28, 2015
-
FierceMedicalDevices |
Neural Analytics is developing portable transcranial Doppler ultrasound devices that it expects could be used by first responders and emergency room physicians to accurately assess mild to severe traumatic brain injury, including concussions.
Dec 22, 2015
-
Labroots |
Stanford scientists identified a specific pattern of gene expression that occurs across different viral infections.
Dec 18, 2015
-
The New York Times |
A screening test may reduce deaths from the hard-to-detect disease, but it needs more study to determine whether it holds up statistically.
Dec 18, 2015
-
Diagnostics World Brief | Novogene and Illumina today announced an agreement to jointly develop advanced clinical applications in the fields of reproductive health and oncology based on next-generation sequencing (NGS) technology. The two companies will work together to develop a user-friendly diagnostic system for clinical prenatal DNA and oncology testing in the Chinese market.
Dec 14, 2015